This inventor holds 3 USPTO granted patents and 9 published patent applications. Top assignees: Savid Therapeutics Inc., The University of Tokyo, Complecure, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024-2026
Title: Masanobu Tsukagoshi: Innovator in Photoimmunotherapy
Introduction
Masanobu Tsukagoshi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of photoimmunotherapy, particularly through his innovative patents. With a total of 3 patents, Tsukagoshi continues to push the boundaries of medical technology.
Latest Patents
One of his latest patents is a conjugate of a biotin-modified dimer and a phthalocyanine dye. This invention aims to provide a conjugate that is utilized in photoimmunotherapy. The compound is represented by a specific formula, which enhances the effectiveness of the treatment. Another notable patent is a clearing agent designed to promptly remove non-localized fusions of streptavidin mutants and molecular probes from the body. This invention addresses the need for efficient clearance of these compounds after administration.
Career Highlights
Throughout his career, Masanobu Tsukagoshi has worked with esteemed organizations such as Savid Therapeutics Inc. and The University of Tokyo. His work in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical science.
Collaborations
Some of his notable coworkers include Motomu Kanai and Kenzo Yamatsugu. Their collaborative efforts have played a crucial role in advancing the research and development of innovative solutions in photoimmunotherapy.
Conclusion
Masanobu Tsukagoshi's work exemplifies the spirit of innovation in the medical field. His patents not only contribute to scientific knowledge but also hold the potential to improve patient outcomes in photoimmunotherapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile